Varghese roams from forests
to enzymes
When Febin Varghese is not puzzling out enzyme structures in the lab, there’s a good chance he’s out on the trail.
The 2020 JBC Herbert Tabor Early Career Investigator Award winners will present their work at the 2021 ASBMB Annual Meeting, 1:45–3 p.m., Tuesday, April 27.
Find out about registering for the annual meeting here.
“When I was really young, I used to watch a lot of documentaries on National Geographic and Discovery Science and such,” Varghese said. “We would watch as a family, and I think that’s where it all started.”
This early interest in the natural world sparked Varghese’s lifelong study of biology both out in the forest and deep inside molecular structures. “I love being in the lab, but I try my best to take breaks,” he said. “Something about being in the mountain air, up in the clouds, stepping away to clear your head, is really refreshing.”
After earning a doctorate at Cambridge University, Varghese embarked on a 15-month backpacking journey throughout Southeast Asia, Australia and New Zealand.
He then returned to the world of metalloenzymes as a postdoc at the Imperial College of London, where researchers in his lab peered into the mystery of how associated proteins protect nitrogen fixation in the presence of oxygen. The project combined Varghese’s interest in energy-conserving metalloenzymes with the potential for long-term environmental applications — an excellent fit. For his contribution to the study as first author on the paper published in the Journal of Biological Chemistry, Varghese won a 2020 Journal of Biological Chemistry/Herbert Tabor Early Career Investigator Award.
“I was very surprised, I wasn’t expecting it at all,” he said of the award. “It’s an honor to be recognized, but a lot of people’s work went into this paper. Collaboration is everything in science.”
Protecting nitrogenase
Nitrogen is abundant in the atmosphere yet scarce in the biosphere; only prokaryotes are equipped with the enzymes necessary to fix atmospheric nitrogen into bioavailable forms. To subvert this limitation and boost crop production, researchers are studying nitrogen-fixing enzymes with the goal of genetically engineering crop plants that can express nitrogenase of their own.
Iron-only nitrogenase, encoded by fewer genes than other nitrogen-fixing enzymes, is a promising candidate for this endeavor. However, it becomes inactive in the presence of oxygen; this barrier must be overcome for it to be expressed functionally in crops.
To explore how the structure of iron-only nitrogenase responds to oxygen, Varghese and colleagues at the James W. Murray lab at the department of life sciences at the Imperial College of London investigated the structure and oxygen-reducing role of Anf3, a protein associated with nitrogenase function.
By characterizing the crystal structure of Anf3 at atomic resolution, the team saw that its heme and flavin adenine dinucleotide cofactors were unexpectedly close to each other.
“The structure itself was a surprise,” Varghese said. “We knew (Anf3) had a heme and an FAD cofactor, but that they were so close together and that there was a cooperative effect was unexpected.”
Further experiments suggested that electron transfer between the two cofactors contributes to Anf3’s ability to reduce oxygen, thus protecting iron-only nitrogenase from being inactivated. Anf3 protein is a promising candidate for enhancing functional nitrogenase in aerobic environments.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.
Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.
ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.
AI can be an asset, ASBMB educators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.
ASBMB undergraduate education programs foster tomorrow’s scientific minds
Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.
Honors for Gagna and Sundquist
Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.